A preprint reports shared lipid changes in frontotemporal degeneration and Alzheimer’s disease
Original source
Shared lipidome and proteome signatures of frontotemporal lobar degeneration and Alzheimer's disease. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
- Peer review
- Preprint, not yet peer reviewed
Population inferred from the title and abstract by Compass.
An integrated analysis of post-mortem brain tissue found broadly shared lipid and protein changes in frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease. The study also identified lipid changes that differed among FTLD subtypes, with the largest alterations in GRN-associated FTLD-TDP and Pick’s disease.
Why this matters
The findings point to shared disturbances in lipid processing and lysosomal pathways across these neurodegenerative diseases. They are molecular observations from post-mortem tissue and do not currently change treatment for people with ALS or FTLD.
Limitations and context
This source is a single preprint reporting a post-mortem tissue study. It does not show that the lipid changes cause disease, can be detected during life, or can be used to guide treatment. The study concerns FTLD and Alzheimer’s disease rather than ALS/MND, so its relevance to ALS remains uncertain.